Somatotropic axis and body weight in pre-menopausal and post-menopausal women: Evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations

Human Reproduction

Volumn 13, Issue 2, 1998, Pages 279-284

  Bernardi, F ^a   Petraglia, F ^b   Seppala, M ^c   Spinetti, A ^a   Bertolini, S ^a   Ferdeghini, M ^a   Genazzani, A R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Arginine; GHRH; IGFBP; Menopause; Obesity

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; SERMORELIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LEAN BODY WEIGHT; NEUROENDOCRINOLOGY; NORMAL HUMAN; OBESITY; POSTMENOPAUSE; PREMENOPAUSE;

EID: 0031937957     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.2.279     Document Type: Article

References (31)

1. Alba-Roth, J., Albrecht Muller, O., Schopohl, J. et al. (1988) Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab., 67, 1186-1189.
2. Blackman, M.R. (1997) Endocrinology and aging. In De Grot, L.J. (ed.), Endocrinology, 3rd edn. New York, pp. 2702-2730.
3. Blum, W.F. and Ranke, M.B. (1990) Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders. Horm. Res., 34 (Suppl.), 31-37.
4. Blum, W.F., Albertsson-Wikland, K., Rosberg, S. et al. (1993) Serum concentrations of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab., 76, 1610-1616.
5. Dawson-Huges, B., Stern, D., Goldman, J. et al. (1986) Regulation of growth hormone and somatomedin-c secretion in postmenopausal women: effect of physiological estrogen replacement. J. Clin. Endocrinol. Metab., 63, 424-432.
6. den Tonkelaar, I., Seidell, J.C., van Noord, F.A.H. et al. (1990) Fat distribution in relation to age, degree of obesity, smoking habits, parity and estrogen use: a cross-sectional study in 11825 Dutch women participating in the DOM-Project. Int. J. Obstet., 14, 753-761.
7. Donahue, L.R., Hunter, S.J., Sherblom, A.P. and Rosen, C. (1990) Age-related changes in serum insulin-like growth factor binding proteins in women. J. Clin. Endocrinol. Metab., 71, 575-579.
8. Ghigo, E., Goffi, S., Nicolosi, M. et al. (1990) Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab., 71, 1481-1485.
9. Ho, K.V., Evans, W.S. and Blizzard, R.M. (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab., 64, 51-58.
10. Homburg, R., Orvieto, R., Bar-Hava, I. and Ben-Rafael, Z. (1996) Serum concentrations of insulin-like growth factor I, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome. Hum. Reprod., 11, 716-719.
11. Jones, J.I. and Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16, 3-33.
12. Jorgensen, J.O.L., Blum, W.F., Moller, N. et al. (1995a) Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. Eur. J. Endocrinol., 133, 65-70.
13. Jorgensen, J.O., Pedersen, S.B., Borglum, J. et al. (1995b) Serum concentration of insulin-like growth factors (IGF), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study. Eur. J. Endocrinol., 133, 65-70.
14. Kim, Y.G. and Lee, J.Y. (1996) Serum insulin-like growth factor binding protein profiles in postmenopausal women: their correlation with bone mineral density. Am. J. Obset. Gynecol., 174, 1511-1517.
15. Koistinen, H., Seppala, M. and Koistinen, R. (1994) Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorimetric assay with monoclonal antibodies. Clin. Chem., 40, 531-536.
16. Koistinen, H., Koistinen, R., Selenius, L. et al. (1996) Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. J. Appl. Physiol., 80, 760-764.
17. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G. et al. (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin. Endocrinol., 41, 351-357.
18. Martikainen, H., Koistinen, R. and Seppala, M. (1992) The effect of estrogen level on glucose-induced changes in serum insulin-like growth factor binding protein-1 concentration. Fertil. Steril., 58, 543-546.
19. Mercuri, M., Petraglia, F., Genazzani, A.D. et al. (1993) Hormonal treatments modulate pulsatile plasma growth hormone, gonadotrophin and osteocalcin levels in postmenopausal women. Maturitas, 17, 51-62.
20. Muller, E.E., Cocchi, D., Ghigo, E. et al. (1993) Growth hormone response to GHRH during lifespan. J. Pediatr. Endocrinol., 6, 5-13.
21. Pasquali, R., Casimirri, F., Labate, A.M.M. et al. (1994) Body weight, fat distribution and menopausal status in women. Int. J. Obstet., 18, 614-621,
22. Procopio, M., Ghigo, E., Invitti, C. et al. (1993) Effect of arginine and pyridostigmine on the GHRH-induced GH rise in patients with Cushing's syndrome or obesity. J. Endocrinol. Invest., 16 (Suppl. 1), 8 (Abstract).
23. Romagnoli, E., Minisola, S., Carnevale, V. et al. (1994) Circulating levels of insulin-like growth factor binding protein 3 (IGFBP-3) and insulin-like growth factor (IGF-I) in premenopausal women. Osteoporos. Int., 4, 305-308 (Abstract).
24. Shirasu, K., Stumpf, W.E. and Sar, M. (1990) Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of estradiol in GRF neurons. Endocrinology, 127, 344-349.
25. Snel, Y.E.M., Doerga, M.E. and Brummer, R.J.M. (1995) Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy. Eur. J. Endocrinol., 133, 445-450.
26. Suikkari, A.M., Ruutiainen, K., Erkkola, R. et al. (1989) Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum. Reprod., 4, 136-139.
27. Suikkari, A.M., Tiitinen, A., Stenman, U.H. et al. (1991) Oral contraceptives increase insulin like growth factor protein-1 concentration in women with polycystic ovarian disease. Fertil. Steril., 55, 895-899.
28. Svendsen, O.L., Hassager, C., Christiansen, C. et al. (1995) Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by Dual-Energy X-Ray Absorptiometry. Metabolism, 44, 369-373.
29. Wehrenberger, W.B. and Giustina, A. (1992) Mechanisms and pathways of gonadal steroid modulation of growth hormone secretion. Endocr. Rev., 13, 299-308.
30. Williams, T., Berelowitz, M., Joffe, S.N. et al. (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. New Engl. J. Med., 311, 1403-1407.
31. Zapf, J., Walter, H. and Froesch, E.R. (1981) Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extra pancreatic tumor hypoglycemia. J. Clin. Invest., 68, 1321-1330.